The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate
NCT02278081 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98
Last updated 2014-10-29
Summary
Gastroesophageal(GERD) reflux disease is a very common problem among pediatric population and has be proved to contribute in numerous otolaryngological manifestations. Trails of empirical treatment of antireflux medications is often used as a diagnostic test. However, the investigators believe GERD can cause rhinitis and nasal obstruction. Nasonex is considered as first line treatment for nasal obstruction. Hence, the proposed study aims to define the relationship between GERD and rhinitis using randomize control trial where one group of patients will receive nasonex and placebo, while the other group will receive nasonex and antireflux medications.
Conditions
- Rhinitis
- Nasal Obstruction
- GERD
Interventions
- DRUG
-
lansoprazole
the lansoprazole will be taken orally.
- DRUG
-
the lansoprazole placebo will be taken orally.
Sponsors & Collaborators
-
McGill University Health Centre/Research Institute of the McGill University Health Centre
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2017-01-31
More Related Trials
-
Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only
NCT01536457 ·Status: COMPLETED
-
Esomeprazole for Treatment of GERD in Pediatric Patients
NCT00228527 ·Status: COMPLETED ·Phase: PHASE4
-
Gastric Reflux and Sinonasal Symptoms
NCT04105894 ·Status: UNKNOWN
-
A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old
NCT02616302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Lansoprazole in Preterm Infants With Reflux
NCT01778101 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3/Safety & Efficacy of Esomeprazole in Infants
NCT00468559 ·Status: COMPLETED ·Phase: PHASE3
-
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)
NCT01946971 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux
NCT01854970 ·Status: COMPLETED ·Phase: NA
-
The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux
NCT00324974 ·Status: COMPLETED ·Phase: PHASE3
-
A New Nasopharyngeal pH Probe for Diagnosis of Laryngopharyngeal Reflux
NCT01308502 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Lansoprazole in Chronic Post Nasal Drip
NCT00335283 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease
NCT00174928 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux
NCT00771706 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients
NCT00427635 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux
NCT00369265 ·Status: TERMINATED ·Phase: PHASE4
-
Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
NCT01808196 ·Status: COMPLETED ·Phase: PHASE2
-
Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
NCT00199953 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study
NCT00963144 ·Status: COMPLETED
-
In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
NCT02700087 ·Status: WITHDRAWN ·Phase: NA
-
The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire
NCT00901004 ·Status: COMPLETED
-
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients
NCT00787891 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease
NCT01045096 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
NCT02615184 ·Status: TERMINATED ·Phase: PHASE2
-
Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis
NCT00175045 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
NCT00390390 ·Status: COMPLETED ·Phase: PHASE3